IDERA PHARMACEUTICALS, INC. (IDRA) is a publicly traded company in the Unknown sector. Across all available filings, 46 corporate insiders have executed 426 transactions totaling $69.7M, demonstrating a bullish sentiment with $24.5M in net insider flow. The most recent transaction on Jan 11, 2023 involved a transaction of 33,523 shares valued at $14.8K.
No significant insider buying has been recorded for IDRA in the recent period.
No significant insider selling has been recorded for IDRA in the recent period.
Based on recent SEC filings, insider sentiment for IDRA is bullish with an Insider Alignment Score of 68/100 and a net flow of $24.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at IDERA PHARMACEUTICALS, INC. (IDRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 46 insiders are actively trading IDRA stock, having executed 426 transactions in the past 90 days. The most active insider is Brothers Life Sciences Lp Baker (Executive), who has made 13 transactions totaling $32.2M.
Get notified when executives and directors at IDRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 11, 2023 | R. Dougherty Michael | Executive | Award | 33,523 | $0.44 | $14.8K | |
| Jan 6, 2023 | J. Kirby John | Executive | Payment | 119,957 | $0.71 | $85.2K | |
| Jan 6, 2023 | J. Kirby John | Executive | Award | 399,218 | $N/A | $0 | |
| Jan 6, 2023 | David Lim Bryant | Executive | Payment | 119,957 | $0.71 | $85.2K | |
| Jan 6, 2023 | David Lim Bryant | Executive | Award | 399,218 | $N/A | $0 | |
| Jan 6, 2023 | R. Jordan Andrew | Executive | Award | 261,718 | $N/A | $0 | |
| Jan 6, 2023 | R. Jordan Andrew | Executive | Payment | 73,940 | $0.71 | $52.5K | |
| Oct 3, 2022 | R. Dougherty Michael | Executive | Award | 58,516 | $0.37 | $21.7K | |
| Sep 28, 2022 | V. Gp, Ltd. Nq Pof | Executive | Other | 5 | $N/A | $0 | |
| Sep 28, 2022 | R. Jordan Andrew | Executive | Award | 651,364 | $N/A | $0 | |
| Sep 28, 2022 | Salain Daniel | Executive | Award | 2,171,214 | $N/A | $0 | |
| Sep 28, 2022 | Clayton Taylor John | Executive | Award | 2,171,214 | $N/A | $0 | |
| Sep 28, 2022 | J. Wooten Ronald | Executive | Other | 5 | $N/A | $0 | |
| Sep 22, 2022 | El Zein Youssef | Executive | Exercise | 1,533,159 | $N/A | $0 | |
| Jul 1, 2022 | R. Dougherty Michael | Executive | Award | 50,086 | $0.44 | $22.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 57 | $47.1M | 53.3% |
Sale(S) | 141 | $22.6M | 25.6% |
Exercise(M) | 23 | $13.9M | 15.8% |
Payment(F) | 7 | $2.6M | 2.9% |
Award(A) | 155 | $2.1M | 2.4% |
Other(J) | 16 | $0 | 0.0% |
Exercise (Options)(X) | 22 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 3 | $0 | 0.0% |
Insiders at IDERA PHARMACEUTICALS, INC. are accumulating shares at an accelerated pace. With 46 insiders making 426 transactions totaling $47.1M in purchases versus $22.6M in sales, the net buying activity of $24.5M signals strong executive confidence. Brothers Life Sciences Lp Baker (Executive) leads the buying activity with $32.2M in transactions across all time.